These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2545638)

  • 1. Methotrexate serum-level determinations during low-dose therapy of rheumatoid and psoriatic arthritis.
    Leeb B; Dunky A; Ogris E; Wohanka A; Schenk G; Gaismayer K; Eberl R
    Int J Clin Pharmacol Res; 1989; 9(3):209-15. PubMed ID: 2545638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Blood cell concentration of methotrexate in long-term therapy of inflammatory rheumatic diseases].
    Leeb B; Dunky A; Ogris E; Wohanka A; Schenk G; Fischer M; Tausch G; Eberl R
    Acta Med Austriaca; 1988; 15(5):140-4. PubMed ID: 3146207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experience with long term low dose methotrexate treatment in rheumatoid arthritis and arthritic psoriasis].
    Náfrádi L; Varga L
    Orv Hetil; 1995 Jul; 136(29):1555-7. PubMed ID: 7637973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate in psoriatic arthritis.
    Singh YN; Verma KK; Kumar A; Malaviya AN
    J Assoc Physicians India; 1994 Nov; 42(11):860-2. PubMed ID: 7868484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological studies in patients with rheumatoid arthritis treated with methotrexate or cyclophosphamide.
    Lacki JK; Schochat T; Sobieska M; Leszczynski P; Wiktorowicz K; Mackiewicz U; Mackiewicz SH; Müller W
    Z Rheumatol; 1994; 53(2):76-82. PubMed ID: 8023589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose weekly oral methotrexate therapy for inflammatory arthritis.
    Boh LE; Schuna AA; Pitterle ME; Adams EM; Sundstrom WR
    Clin Pharm; 1986 Jun; 5(6):503-8. PubMed ID: 3720217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
    Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS
    J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
    Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
    Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects on fibrogenesis markers of rheumatoid arthritis therapy with methotrexate.
    Biasi D; Bambara LM; Carletto A; Casaril M; Capra F; Caramaschi P; Corrocher R
    J Rheumatol; 1996 Mar; 23(3):453-4. PubMed ID: 8832981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis.
    Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
    J Rheumatol; 2002 May; 29(5):883-9. PubMed ID: 12022344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of the effect of the antimetabolic agent methotrexate in psoriasis, psoriatic arthropathy and rheumatoid arthritis].
    Siegmeth W; Eberl R; Tausch G; Raith W
    Verh Dtsch Ges Rheumatol; 1969; 1():383-7. PubMed ID: 5403653
    [No Abstract]   [Full Text] [Related]  

  • 13. Leflunomide and methotrexate reduce levels of activated matrix metalloproteinases in complexes with alpha2 macroglobulin in serum of rheumatoid arthritis patients.
    Tchetverikov I; Kraan MC; van El B; Hanemaaijer R; DeGroot J; Huizinga TW
    Ann Rheum Dis; 2008 Jan; 67(1):128-30. PubMed ID: 17875551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis.
    Thompson RN; Watts C; Edelman J; Esdaile J; Russell AS
    J Rheumatol; 1984 Dec; 11(6):760-3. PubMed ID: 6394758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose intravenous methotrexate with leucovorin rescue in rheumatoid arthritis.
    Shiroky J; Allegra C; Inghirami G; Chabner B; Yarboro C; Klippel JH
    J Rheumatol; 1988 Feb; 15(2):251-5. PubMed ID: 3258915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
    Kremer JM; Weinblatt ME; Bankhurst AD; Bulpitt KJ; Fleischmann RM; Jackson CG; Atkins KM; Feng A; Burge DJ
    Arthritis Rheum; 2003 Jun; 48(6):1493-9. PubMed ID: 12794815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between tumor necrosis factor inhibitor (TNFi) therapy and changes in C-reactive protein (CRP), blood pressure, and alanine aminotransferase (ALT) among patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis.
    Wu JJ; Rowan CG; Bebchuk JD; Anthony MS
    J Am Acad Dermatol; 2015 May; 72(5):917-9. PubMed ID: 25748312
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxicity of low dose methotrexate in rheumatoid arthritis.
    Weinblatt ME
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():35-9. PubMed ID: 3913775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis.
    Wolbink GJ; Voskuyl AE; Lems WF; de Groot E; Nurmohamed MT; Tak PP; Dijkmans BA; Aarden L
    Ann Rheum Dis; 2005 May; 64(5):704-7. PubMed ID: 15485995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alpha 1-fetoprotein--a marker of potential PUVA side-effects in psoriasis?].
    Wollina U; Schulze M; Schaarschmidt H; Barta U; Pfeiffer L; Knopf B; Horn A
    Z Hautkr; 1985 Mar; 60(6):527-30. PubMed ID: 2581382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.